Legal

Accessibility statement.

---

NeuroNova Therapeutics wants this website to be usable by everyone. Our conformance target is the Web Content Accessibility Guidelines (WCAG) 2.2, Level AA.

Measures taken

The site uses semantic HTML with a single, ordered heading structure per page; a skip-to-content link; visible keyboard focus indicators; text alternatives for meaningful images and diagrams; a color palette audited for contrast, with red used for body-size text only in its darker, higher-contrast variant; resizable text without loss of function; and no autoplaying media, parallax effects, or motion-triggered content.

Known limitations

The site is young and under active review. If any page element does not meet the standard above, that is a defect we want to know about.

Feedback

If you encounter an accessibility barrier on this site, email harrison.mirzaei@neuronovatherapeutics.com with the page address and a description of the problem. We will make reasonable efforts to address it promptly.